New Approach to Medicare Part D

New Approach to Medicare Part D

In a significant overhaul of Medicare Part D, set to take effect in 2025, beneficiaries are poised to experience a transformative change in how prescription drug benefits are structured and financed.

The Centers for Medicare & Medicaid Services (CMS) recently unveiled the Final Calendar Year (CY) 2025 Part D Redesign Program Instructions, a comprehensive guide that outlines the forthcoming changes under the Inflation Reduction Act of 2022. This announcement is in tandem with the CY 2025 Medicare Advantage and Part D payment policies, indicating a pivotal shift in the landscape of Medicare prescription coverage.

The Inflation Reduction Act of 2022 (IRA), a landmark legislation, has initiated a series of amendments to the Social Security Act that will fundamentally alter the Part D drug benefit structure. Beginning Jan. 1, 2025, the new framework introduces a redesigned benefit program, aiming to provide significant financial relief to enrollees by introducing a lower annual out-of-pocket (OOP) threshold, terminating the Coverage Gap Discount Program (CGDP), and inaugurating the Manufacturer Discount Program.

At the heart of the 2025 redesign is the establishment of a three-phase standard Part D benefit structure: the annual deductible phase, the initial coverage phase, and the catastrophic coverage phase. This structure is designed to streamline the benefits while focusing on reducing the financial burden on beneficiaries. One of the most notable changes is the reduction of the annual OOP threshold to $2,000, a substantial decrease that promises to alleviate the cost burden on Medicare beneficiaries.

The phasing out of the CGDP and the introduction of the Manufacturer Discount Program mark a pivotal change in the way prescription drug costs are managed. The Manufacturer Discount Program is set to replace the CGDP, shifting the focus towards providing discounts directly from manufacturers to enrollees, thereby ensuring that beneficiaries receive more immediate financial relief on prescription drugs.

Another critical aspect of the redesign is the reevaluation of what constitutes the True Out-of-Pocket Costs (TrOOP). Under the new guidelines, the IRA updates the categories of payments that count towards TrOOP, expanding the scope to include payments for previously excluded supplemental benefits, thereby providing a broader safety net for beneficiaries.

The policy also addresses the coverage of drugs not subject to the standard deductible, such as certain insulins and vaccines. In these instances, beneficiaries who have not met their plan deductible but have incurred sufficient TrOOP-eligible costs will be deemed to have satisfied their deductible, ensuring that they can access these essential medications without financial barriers.

A significant revision is also made to the government reinsurance calculation methodology for CY 2025. The IRA stipulates that the calculation of reinsurance payments will now depend on the type of drug, necessitating a corresponding adjustment in the Direct and Indirect Remuneration (DIR) allocation methodology. This change ensures a more equitable distribution of costs and reflects the varied nature of prescription drug usage among beneficiaries.

Furthermore, the redesign introduces a new perspective on Enhanced Alternative (EA) plans, limiting the available options for sponsors to enhance their benefits. The CMS will utilize the Part D Out-of-Pocket Costs (OOPC) model to estimate the value of EA plans relative to the standard benefit, ensuring that enrollees receive tangible value from opting for an EA plan.

In summary, the CY 2025 Part D benefit redesign under the IRA represents a comprehensive effort to modernize Medicare prescription drug coverage, making it more affordable and accessible for beneficiaries. By introducing a lower annual OOP threshold, establishing the Manufacturer Discount Program, and revising the calculation methodologies for TrOOP and government reinsurance, the redesign aims to provide a more equitable and sustainable framework for Medicare Part D.

As we approach 2025, beneficiaries and stakeholders alike are encouraged to familiarize themselves with these changes, ensuring a smooth transition to the new benefit structure.

Facebook
Twitter
LinkedIn

Timothy Powell, CPA, CHCP

Timothy Powell is a nationally recognized expert on regulatory matters, including the False Claims Act, Zone Program Integrity Contractor (ZPIC) audits, and U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) compliance. He is a member of the RACmonitor editorial board and a national correspondent for Monitor Mondays.

Related Stories

Medical Necessity: The Next Frontier for CDI

Medical Necessity: The Next Frontier for CDI

EDITOR’S NOTE: The author of this article used AI-assisted tools in its composition, but all content, analysis, and conclusions were based on the author’s professional

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering OB GYN Coding Accuracy: Precision Coding for Compliance and Reimbursement

Gain clarity and confidence in OB‑GYN coding with this expert‑led webcast featuring Stacey Shillito, CDIP, CPMA, CCS, CCS‑P, CPEDC, COPC. You’ll learn how to apply global maternity package rules accurately, select the right CPT codes for procedures and visits, and identify documentation gaps that lead to denials. With practical guidance and real examples, this session helps you strengthen compliance, reduce audit risk, and ensure accurate reimbursement for women’s health services.

May 14, 2026

2026 ICD-10-CM/PCS Coding Clinic Update Webcast Series

Uncover essential coding insights with nationally recognized coding authority Kay Piper, RHIA, CDIP, CCS. Through ICD10monitor’s interactive, on‑demand webcast series, Kay walks you through the AHA’s 2026 ICD‑10‑CM/PCS Quarterly Coding Clinics, translating each update into practical, easy‑to‑apply guidance designed to sharpen precision, ensure compliance, and strengthen day‑to‑day decision‑making. Available shortly after each official release.

April 13, 2026

2026 ICD-10-CM/PCS Coding Clinic Update: Fourth Quarter

Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s fourth quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.

December 14, 2026

2026 ICD-10-CM/PCS Coding Clinic Update: Third Quarter

Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s third quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.

October 12, 2026

Trending News

Featured Webcasts

Compliance for the Inpatient Psychiatric Facility (IPF-PPS): Minimizing Federal Audit Findings by Strengthening Best Practices

Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.

April 9, 2026

Mastering MDM for Accurate Professional Fee Coding

In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.

March 31, 2026

The PEPPER Returns – Risk and Opportunity at Your Fingertips

Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.

March 19, 2026

Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue

Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.

January 29, 2026

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

BLOOM INTO SAVINGS! Get 25% OFF during our spring sale through March 27. Use code SPRING26 at checkout to claim this offer.

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24